Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PLL, SAVA and SPPI By: The Klein Law Firm via AccessWire September 09, 2021 at 10:30 AM EDT NEW YORK, NY / ACCESSWIRE / September 9, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.Piedmont Lithium Inc. (NASDAQ:PLL)Class Period: March 16, 2018 - July 19, 2021Lead Plaintiff Deadline: September 21, 2021Throughout the class period, Piedmont Lithium Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Piedmont has not, and would not, follow its stated steps or timeline to secure all proper and necessary permits; (2) Piedmont failed to inform relevant people and governmental authorities of its actual plans; (3) Piedmont failed to file proper applications with relevant governmental authorities (including state and local authorities); (4) Piedmont and its lithium business does not have "strong local government support"; and (5) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.Learn about your recoverable losses in PLL: https://www.kleinstocklaw.com/pslra-1/piedmont-lithium-inc-loss-submission-form?id=19429&from=1Cassava Sciences, Inc. (NASDAQ:SAVA)Class Period: February 2, 2021 - August 24, 2021Lead Plaintiff Deadline: October 26, 2021Cassava Sciences, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and/or lacked a reasonable basis.Learn about your recoverable losses in SAVA: https://www.kleinstocklaw.com/pslra-1/cassava-sciences-inc-loss-submission-form?id=19429&from=1Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Class Period: December 27, 2018 - August 5, 2021Lead Plaintiff Deadline: November 1, 2021The complaint alleges that throughout the class period Spectrum Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.Learn about your recoverable losses in SPPI: https://www.kleinstocklaw.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?id=19429&from=1Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118jk@kleinstocklaw.comTelephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.comSOURCE: The Klein Law FirmView source version on accesswire.com: https://www.accesswire.com/663350/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-PLL-SAVA-and-SPPI Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PLL, SAVA and SPPI By: The Klein Law Firm via AccessWire September 09, 2021 at 10:30 AM EDT NEW YORK, NY / ACCESSWIRE / September 9, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.Piedmont Lithium Inc. (NASDAQ:PLL)Class Period: March 16, 2018 - July 19, 2021Lead Plaintiff Deadline: September 21, 2021Throughout the class period, Piedmont Lithium Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Piedmont has not, and would not, follow its stated steps or timeline to secure all proper and necessary permits; (2) Piedmont failed to inform relevant people and governmental authorities of its actual plans; (3) Piedmont failed to file proper applications with relevant governmental authorities (including state and local authorities); (4) Piedmont and its lithium business does not have "strong local government support"; and (5) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.Learn about your recoverable losses in PLL: https://www.kleinstocklaw.com/pslra-1/piedmont-lithium-inc-loss-submission-form?id=19429&from=1Cassava Sciences, Inc. (NASDAQ:SAVA)Class Period: February 2, 2021 - August 24, 2021Lead Plaintiff Deadline: October 26, 2021Cassava Sciences, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the quality and integrity of the scientific data supporting Cassava's claims for simufilam's, a small molecule drug designed to treat Alzheimer's disease, efficacy had been overstated; (b) the scientific data supporting Cassava's claims for simufilam's efficacy were biased; and (c) as a result of the foregoing, Defendants' positive statements during the Class Period about the Company's business metrics and financial prospects and the likelihood of Food and Drug Administration approval were false and misleading and/or lacked a reasonable basis.Learn about your recoverable losses in SAVA: https://www.kleinstocklaw.com/pslra-1/cassava-sciences-inc-loss-submission-form?id=19429&from=1Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)Class Period: December 27, 2018 - August 5, 2021Lead Plaintiff Deadline: November 1, 2021The complaint alleges that throughout the class period Spectrum Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.Learn about your recoverable losses in SPPI: https://www.kleinstocklaw.com/pslra-1/spectrum-pharmaceuticals-inc-loss-submission-form?id=19429&from=1Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.CONTACT:J. Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118jk@kleinstocklaw.comTelephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.comSOURCE: The Klein Law FirmView source version on accesswire.com: https://www.accesswire.com/663350/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-PLL-SAVA-and-SPPI